[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Friday when compared to competitors despite daily gains",
    "summary": "Boston Scientific Corp. stock underperforms Friday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=56785dfd5a9178f229d508e52c2cd3f9bc54f14959bcdd91ad1d51566738705a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759509360,
      "headline": "Boston Scientific Corp. stock underperforms Friday when compared to competitors despite daily gains",
      "id": 137016959,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Friday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=56785dfd5a9178f229d508e52c2cd3f9bc54f14959bcdd91ad1d51566738705a"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  Arbutus Biopharma (ABUS) This Year?",
    "summary": "Here is how Arbutus Biopharma (ABUS) and Boston Scientific (BSX) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=89482b0e305f010007f5ab8afcfe63b8063df438d4bcad391144a9dbf4047320",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759498803,
      "headline": "Are Medical Stocks Lagging  Arbutus Biopharma (ABUS) This Year?",
      "id": 136980919,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Here is how Arbutus Biopharma (ABUS) and Boston Scientific (BSX) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=89482b0e305f010007f5ab8afcfe63b8063df438d4bcad391144a9dbf4047320"
    }
  },
  {
    "ts": null,
    "headline": "Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX)",
    "summary": "Boston Scientific (BSX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.",
    "url": "https://finnhub.io/api/news?id=aeadce6303dd3e67708ec03940bad9beb5623c840ba1483b0a154f8f3f56028a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759498501,
      "headline": "Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX)",
      "id": 136980920,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.",
      "url": "https://finnhub.io/api/news?id=aeadce6303dd3e67708ec03940bad9beb5623c840ba1483b0a154f8f3f56028a"
    }
  },
  {
    "ts": null,
    "headline": "HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests",
    "summary": "Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.",
    "url": "https://finnhub.io/api/news?id=d41bdbf3c5f9c8ddc5ade3da414e2d01c416496f1294cefd6c9141ffc0527714",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759494060,
      "headline": "HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests",
      "id": 136964374,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.",
      "url": "https://finnhub.io/api/news?id=d41bdbf3c5f9c8ddc5ade3da414e2d01c416496f1294cefd6c9141ffc0527714"
    }
  },
  {
    "ts": null,
    "headline": "RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT",
    "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best medical stocks to buy now. On September 29, RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific Corporation (NYSE:BSX) and set a price target of $125.00. Boston Scientific Corporation (NYSE:BSX) reported in its fiscal Q2 2025 earnings that net sales for the […]",
    "url": "https://finnhub.io/api/news?id=9d78524c7b05fb7f77e18dd7839d0d2c6c192c821bbf7d342508b9ed261c79ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759487272,
      "headline": "RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT",
      "id": 136963250,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best medical stocks to buy now. On September 29, RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific Corporation (NYSE:BSX) and set a price target of $125.00. Boston Scientific Corporation (NYSE:BSX) reported in its fiscal Q2 2025 earnings that net sales for the […]",
      "url": "https://finnhub.io/api/news?id=9d78524c7b05fb7f77e18dd7839d0d2c6c192c821bbf7d342508b9ed261c79ca"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic wins CE mark for Penditure LAA exclusion device",
    "summary": "The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.",
    "url": "https://finnhub.io/api/news?id=50f442254ff2ec6a42cb44acf87c2269958c2382c2de1622871e1cf70a54d8b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759485240,
      "headline": "Medtronic wins CE mark for Penditure LAA exclusion device",
      "id": 136965101,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.",
      "url": "https://finnhub.io/api/news?id=50f442254ff2ec6a42cb44acf87c2269958c2382c2de1622871e1cf70a54d8b1"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco",
    "summary": "BSX, UNP, O, and WEYS stand out with strong sector performance, resilient cash flows, and strategic growth moves, despite headwinds from tariffs, e-commerce, and macro uncertainties.",
    "url": "https://finnhub.io/api/news?id=93f3ccd94708a19ce6824b6f9bd17ac23c71d00e760c4b9c502df36a3eda7740",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759482060,
      "headline": "The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco",
      "id": 136963251,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BSX, UNP, O, and WEYS stand out with strong sector performance, resilient cash flows, and strategic growth moves, despite headwinds from tariffs, e-commerce, and macro uncertainties.",
      "url": "https://finnhub.io/api/news?id=93f3ccd94708a19ce6824b6f9bd17ac23c71d00e760c4b9c502df36a3eda7740"
    }
  },
  {
    "ts": null,
    "headline": "Barclays Maintains Boston Scientific (BSX) Overweight Recommendation",
    "summary": "Barclays Maintains Boston Scientific (BSX) Overweight Recommendation",
    "url": "https://finnhub.io/api/news?id=8c4eab1a26121dfcafc53a0ed78607547d056320342666a38774b0135742fa91",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759449986,
      "headline": "Barclays Maintains Boston Scientific (BSX) Overweight Recommendation",
      "id": 136958476,
      "image": "",
      "related": "BSX",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=8c4eab1a26121dfcafc53a0ed78607547d056320342666a38774b0135742fa91"
    }
  }
]